5-HYDROXYTRYPTAMINE - NEW RECEPTORS AND NOVEL DRUGS FOR GASTROINTESTINAL MOTOR DISORDERS

被引:95
作者
COSTALL, B
NAYLOR, RJ
机构
[1] Postgraduate Studies in Pharmacology, The School of Pharmacy, University of Bradford, Bradford, West Yorkshire
关键词
D O I
10.3109/00365529008999215
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:769 / 787
页数:19
相关论文
共 146 条
[1]   EFFECT OF ICS 205-930 (A SPECIFIC 5-HT3 RECEPTOR ANTAGONIST) ON GASTRIC-EMPTYING OF A SOLID MEAL IN NORMAL SUBJECTS [J].
AKKERMANS, LMA ;
VOS, A ;
HOEKSTRA, A ;
ROELOFS, JMM ;
HOROWITZ, M .
GUT, 1988, 29 (09) :1249-1252
[2]   ANTAGONISM OF CISPLATIN-INDUCED EMESIS BY METOCLOPRAMIDE AND DAZOPRIDE THROUGH ENHANCEMENT OF GASTRIC-MOTILITY [J].
ALPHIN, RS ;
PROAKIS, AG ;
LEONARD, CA ;
SMITH, WL ;
DANNENBURG, WN ;
KINNIER, WJ ;
JOHNSON, DN ;
SANCILIO, LF ;
WARD, JW .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (05) :524-529
[3]   REMISSION OF SYMPTOMS IN CARCINOID-SYNDROME WITH A NEW 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONIST [J].
ANDERSON, JV ;
COUPE, MO ;
MORRIS, JA ;
HODGSON, HJF ;
BLOOM, SR .
BRITISH MEDICAL JOURNAL, 1987, 294 (6580) :1129-1129
[4]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[5]  
[Anonymous], [No title captured]
[6]   NEURONAL INVOLVEMENT IN TYPE-1 HYPERSENSITIVITY REACTIONS IN GUT EPITHELIA [J].
BAIRD, AW ;
CUTHBERT, AW .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (03) :647-655
[7]   THE ACTION OF CISAPRIDE ON GASTRIC-EMPTYING AND THE PHARMACODYNAMICS AND PHARMACOKINETICS OF ORAL DIAZEPAM [J].
BATEMAN, DN .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (02) :205-208
[8]  
BIEGER D, 1989, INT S SEROTONIN CELL, P159
[9]  
BOECKXSTAENS GE, 1989, INT S SEROTONIN CELL, P117
[10]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576